ABO-incompatible liver transplantation for severe hepatitis B patients

Jian Zhou, Weiqiang Ju, Xiaopeng Yuan, Xingyuan Jiao, Xiaofeng Zhu, Dongping Wang, Xiaoshun He

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

Effect of ABO-incompatible liver transplantation on patients with severe hepatitis B (SHB) remains unclear. Herein, we summarized 22 cases with SHB in whom were performed emergency liver transplantation from ABO-incompatible donors. The immunosuppressive protocol consisted basiliximab, tacrolimus, steroids and mycophenolate mofetil. The mean MELD score was 35.2 ± 7.1. Major complications included rejection, infections, biliary complications, hepatic artery thrombosis or stenosis and portal vein thrombosis. Patient survival rates were 40.9%, 78.9% and 82.3% in 1 year, 29.2%, 66.8% and 72.9% in 3 years, and 21.9%, 60.1% and 62.5% in 5 years for ABO-incompatible, ABO-compatible and ABO-identical groups. Graft survival rates were 39%, 78.9% and 82.3% in 1 year, 27.8%, 66.4% and 71.1% in 3 years, and 20.9%, 57.9% and 61.0% in 5 years for incompatible, compatible and identical ABO graft-recipient match. The 1-, 3-, 5-year graft and patient survival rates of ABO-incompatible were distinctly lower than that of ABO-compatible group (P < 0.05). Our results suggested that ABO-incompatible liver transplantation might be a life-saving procedure for patients with SHB as a promising alternative operation when ABO-compatible donors are not available and at least bridges the second opportunity for liver retransplantation.

Original languageEnglish (US)
Pages (from-to)793-799
Number of pages7
JournalTransplant International
Volume28
Issue number7
DOIs
StatePublished - Jul 1 2015

Keywords

  • ABO blood-group system
  • ABO-incompatible
  • blood group incompatibility
  • liver failure
  • liver transplantation
  • severe hepatitis B

ASJC Scopus subject areas

  • Transplantation

Fingerprint

Dive into the research topics of 'ABO-incompatible liver transplantation for severe hepatitis B patients'. Together they form a unique fingerprint.

Cite this